Vorinostat Completed Phase 1 Trials for Hodgkins Disease (HD) / Non-Hodgkin's Lymphoma (NHL) Treatment

Indications	Status	Purpose	Phase
DBCOND0071554 (Hodgkins Disease (HD)) DBCOND0030854 (Non-Hodgkin's Lymphoma (NHL))	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT00691210	Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies	Etoposide (DB00773) Nicotinamide (DB02701) Vorinostat (DB02546)